A post-marketing evaluation of the impact of neutralizing antibodies on the effectiveness of interferon beta in relapsing-remitting multiple sclerosis

被引：0
|
作者：
Paolicelli, Damiano [1 ]
Lavolpe, Vito [1 ]
Pellegrini, Fabio [2 ]
Ruggieri, Maddalena [1 ]
Fuiani, Aurora [1 ]
D'Onghia, Mariangela [1 ]
Laffaldano, Pietro [1 ]
Livrea, Paolo [1 ]
Trojano, Maria [1 ]
机构：
[1] Univ Bari, Dept Neurol & Psychiat Sci, Bari, Italy
[2] Mario Negri Sud Consortium, Dept Clin Pharmacol & Epidemiol, Santa Maria Imbaro, Italy
来源：
MULTIPLE SCLEROSIS | 2008年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S24 / S24
页数：1
相关论文
共 50 条
  • [1] Interferon beta treatment in relapsing-remitting multiple sclerosis: a post-marketing study in Lombardia, Italy
    Milanese, C
    La Mantia, L
    Palumbo, R
    [J]. ITALIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1999, 20 (05): : 297 - 302
  • [2] Interferon beta treatment in relapsing-remitting multiple sclerosis: a post-marketing study in Lombardia, Italy
    C. Milanese
    L. La Mantia
    R. Palumbo
    [J]. The Italian Journal of Neurological Sciences, 1999, 20 : 297 - 302
  • [3] Neutralizing antibodies and the efficacy of interferon beta-1b in relapsing-remitting multiple sclerosis
    Petkau, J
    White, R
    [J]. MULTIPLE SCLEROSIS, 1997, 3 (06): : 402 - 402
  • [4] The importance of neutralizing antibodies in relapsing-remitting multiple sclerosis
    Baetu, C.
    Martin, R. E.
    Buraga, I.
    [J]. JOURNAL OF NEUROLOGY, 2013, 260 : S224 - S225
  • [5] Impact of discontinuing interferon beta in patients with relapsing-remitting multiple sclerosis
    Agiela, Mabroka I. M.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (06) : NP5 - NP5
  • [6] The clinical importance of neutralizing antibodies in relapsing-remitting multiple sclerosis
    Namaka, M
    Pollitt-Smith, M
    Gupta, A
    Klowak, M
    Vasconcelos, M
    Turcotte, D
    Gong, YW
    Melanson, M
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (02) : 223 - 239
  • [7] The use of interferon beta in relapsing-remitting multiple sclerosis
    Etheridge, LJ
    Beverley, DW
    Ferrie, C
    McManus, E
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2004, 89 (08) : 789 - 791
  • [8] THE COST OF PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS WHO DEVELOP NEUTRALIZING ANTIBODIES WHILE TREATED WITH INTERFERON BETA
    Paolicelli, D.
    Iannazzo, S.
    Santoni, L.
    D'Onghia, M.
    Direnzo, V
    Iaffaldano, A.
    Puma, E.
    Di Lecce, V
    Trojano, M.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A754 - A754
  • [9] The Cost of Relapsing-Remitting Multiple Sclerosis Patients Who Develop Neutralizing Antibodies during Interferon Beta Therapy
    Paolicelli, Damiano
    Iannazzo, Sergio
    Santoni, Laura
    Iaffaldano, Antonio
    Di Lecce, Valentina
    Manni, Alessia
    Lavolpe, Vito
    Tortorella, Carla
    D'Onghia, Mariangela
    Direnzo, Vita
    Puma, Elisa
    Trojano, Maria
    [J]. PLOS ONE, 2016, 11 (07):
  • [10] Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing-remitting multiple sclerosis
    Petkau, AJ
    White, RA
    Ebers, GC
    Reder, AT
    Sibley, WA
    Lublin, FD
    Paty, DW
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2004, 10 (02) : 126 - 138
12345